---
schema_version: "secwatch.filing_event.v1"
accession: "0001613103-23-000117"
form_type: "8-K"
ticker: "MDT"
cik: "0001613103"
company_name: "Medtronic plc"
filed_at: "2023-08-22T23:59:59+00:00"
generated_at: "2026-06-11T05:37:19.796534+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Medtronic Q1 revenue $7.7B (+6% organic); raises FY24 guidance

## Summary
- Revenue $7.70B, +4.5% reported, +6.0% organic; GAAP EPS $0.59 (-16%), non-GAAP EPS $1.20 (+6%).
- FY24 organic revenue growth guidance raised to 4.5% (from 4.0-4.5%); non-GAAP EPS guidance raised to $5.08-$5.16 (from $5.00-$5.10).
- All four segments delivered 6% organic growth: Cardiovascular +6.2%, Neuroscience +5.6%, Medical Surgical +6.1%, Diabetes +6.3%.
- U.S. launches commenced for MiniMed 780G system and Micra AV2/VR2 leadless pacemakers.
- Management cites broad strength and improved fundamentals; raises guidance based on Q1 outperformance.

## SEC filing metadata
- accession: 0001613103-23-000117
- form_type: 8-K
- ticker: MDT
- cik: 0001613103
- company_name: Medtronic plc
- filed_at: 2023-08-22T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000117/0001613103-23-000117-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000117/mdt-20230822.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001613103-23-000117
- JSON: https://secwatch.observer/filing/0001613103-23-000117.json
- Plain text: https://secwatch.observer/filing/0001613103-23-000117.txt

## Key facts
- Earnings Releases
  Medtronic plc reported first quarter of fiscal year 2024 (FY24), which ended July 28, 2023 results: revenue $7.702 billion, net income $791 million, EPS $0.59. Guidance raised.
  - Period: first quarter of fiscal year 2024 (FY24), which ended July 28, 2023
  - Revenue: $7.702 billion
  - Net income: $791 million
  - EPS: $0.59
  - Guidance: raised
  - Result: reported results
  source text: Medtronic plc (NYSE:MDT) today announced financial results for its first quarter of fiscal year 2024 (FY24), which ended July 28, 2023. Key Highlights • Revenue of $7.7 billion increased 4.5% as reported and 6.0% organic • GAAP diluted earnings per share (EPS) of $0.59 decreased 16%; non-GAAP diluted EPS of $1.20 increased 6% • Company increases FY24 organic revenue growth and EPS guidance
  evidence_url: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000117/0001613103-23-000117-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.